Clinical Trial: Efficacy, Safety, Tolerability of Carbavance Compared to Piperacillin/Tazobactam in Complicated Urinary Tract Infections (cUTIs), Including Acute Pyelonephritis (AP), in Adults

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

---

Official Title: A Phase 3, Multi-Center, Randomized, Double-Blind, Double-Dummy Study to Evaluate the Efficacy, Safety, and Tolerability of Carbavance (Meropenem/Vaborbactam) Compared to Piperacillin/Tazobactam in th

Brief Summary: Carbavance, (meropenem/vaborbactam) is being compared to piperacillin/tazobactam in the treatment of adults with cUTIs or AP